SonoVue - Bracco
WEBContrast-enhanced ultrasound. Bringing value. to. diagnostic imaging. Diagnosis is the first step in the adequate management of patients and a key aspect of healthcare: diagnosis allows for an understanding of a patient's particular health condition and guides subsequent healthcare decisions.
Sonovue - Bracco
WEBSonoVue ® is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease, to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation 5.
SonoVue | European Medicines Agency (EMA)
WEBSonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.
WEBSonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation. Doppler of macrovasculature.
Safety With Echocardiographic Contrast Agents | Circulation ...
WEBApr 4, 2017 · Soman et al 65 evaluated the safety of Sonovue (marketed in the United States as Lumason) in 13 patients with severe left ventricular systolic dysfunction (11 of whom had concomitant pulmonary hypertension). After sequential administration of 2 and 4 mL of Sonovue, there were no changes in pulmonary hemodynamics.
A review of contrast-enhanced ultrasound using SonoVue® and …
WEBOct 1, 2023 · A judicious selection of ultrasound contrast agent (UCA) is imperative for optimizing imaging and improving diagnosis. Approved UCAs for imaging the majority of organs include SonoVue, a pure blood agent, and Sonazoid, which exhibits an …
SonoVue - patient leaflet, side effects, dosage
WEBSonoVue is for diagnostic use only. SonoVue is an ultrasound contrast agent that contains tiny bubbles filled with a gas called sulphur hexafluoride. If you are an adult, SonoVue helps to obtain clearer ultrasound pictures of your heart, your blood vessels and/or tissues of the liver and breast.
Clinical usefulness of SonoVue contrast echocardiography: the ...
WEBBecause of the sometimes low quality of echocardiographic images we started to use an ultrasound contrast agent and in this article we describe our experiences with SonoVue, a second-generation contrast agent, over a threeyear period in the Thoraxcentre.
SonoVue - National Center for Biotechnology Information
WEBJan 1, 2022 · SonoVue ® or Optison™ are typically best at lower intensities (<15 mW/cm 2) but Sonazoid™ was best at higher ultrasound intensities (>15 mW/cm 2). The general trend observed across all three cell lines is that SonoVue ® is the best microbubble below 15 mW/cm 2 (I SPTA ).
WEBSonoVue (Bracco UK), a pharmaceutical agent for diagnostic use only, is a contrast agent involving sulphur hexafluoride microbubbles. It is indicated for contrast-enhanced ultrasound imaging in adults when unenhanced imaging has been inconclusive. SonoVue has a European marketing authorisation for use in
- Some results have been removed
Skip to content